The Effect of Exercise on Motion Perception and Fear in Low Back Pain
Launched by SULEYMAN DEMIREL UNIVERSITY · Jun 21, 2022
Trial Information
Current as of June 13, 2025
Unknown status
Keywords
ClinConnect Summary
The study will be composed of volunteers, non-specific low back pain individuals who meet the inclusion criteria. First of all, the demographic and clinical characteristics of the patients will be questioned with the evaluation form. The personal information of the patients (gender, height, weight, smoking, etc.) and clinical status (pain type, pain intensity, trunk flexibility measurements) will be recorded by the physiotherapist in the evaluation form. In addition to these measurements, the state of fear of physical movement and activity will be evaluated with the Tampa Kinesiophobia Scale.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Voluntarily accepting the study
- • Having nonspecific low back pain for 3 months or longer
- • Not having had spinal surgery in the last 6 months
- • Not having an orthopedic or neurological disability that would prevent them from doing their exercises
- • Patients who regularly continue their exercises without interrupting
- Exclusion Criteria:
- • Patients with non-specific low back pain who do not meet the inclusion criteria and want to drop out of the study
About Suleyman Demirel University
Suleyman Demirel University is a prominent educational and research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, the university collaborates with healthcare professionals and researchers to explore new therapeutic approaches and enhance patient care. Its clinical trial initiatives focus on a range of medical fields, aiming to contribute valuable insights to the scientific community and foster the development of effective treatment strategies. By prioritizing ethical standards and rigorous methodologies, Suleyman Demirel University plays a pivotal role in shaping the future of healthcare through evidence-based research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Isparta, , Turkey
Patients applied
Trial Officials
Mine ARGALI DENIZ, PT, PhD
Study Director
Suleyman Demirel University Education and Training Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials